logo-large
  • Browse Categories

Publications by authors named "Sulong Lv"

Claim this Profile
K
Knockdown of RRBP1 regulates endoplasmic reticulum stress to mitigate malignant progression and suppress bortezomib resistance of multiple myeloma cells by inhibiting GRP78 expression.
Jie Wang, Haipeng Jia, Sulong Lv, Xiaofen Zhang, Yanchao Duan

Mol Immunol· July 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2.
Haipeng Jia, Yan Liu, Sulong Lv, Ruifang Qiao, Xiaofen Zhang

Front Mol Biosci· September 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FABP5, a Novel Immune-Related mRNA Prognostic Marker and a Target of Immunotherapy for Multiple Myeloma.
Haipeng Jia, Xiaofen Zhang, Xinxin Liu, Ruifang Qiao, Yan Liu, Sulong Lv

Front Med (Lausanne)· June 2021


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: